BrainX Corporation
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia (NCT03413384) | BrainX Corporation | 2019-02-15 |
Track BrainX Corporation automatically
Every clearance here is in the API, with alerts when new ones post.